WHO Says Solidarity Clinical Trial Enters New Phase With Three New Candidate Drugs For Treating COVID-19; Artesunate, Imatinib And Infliximab Were Selected By An Independent Expert Panel For Potential In Reducing The Risk Of Death In Hospitalized Patients